ecancermedicalscience

Case Report

Immunotherapy and local therapies in metastatic laryngeal cancer management: a case report

17 Jul 2025
João Felipe Lima Feldmann, João Henrique Lima Feldmann, Cassio Murilo Hidalgo-Filho, Amanda Acioli de Almeida Robatto, Breno Jeha Araújo, Publio Cesar Cavalcante Viana, Gilberto de Castro Junior

Background: Advanced laryngeal carcinoma (LC) has a poor prognosis with limited treatment options. Managing oligometastasis is challenging, and there are currently no standard recommendations.

Methods: We reported a case of a 64-year-old male with locally advanced LC who developed oligometastatic disease in the bones and liver 21 months after concurrent cisplatin-based chemoradiotherapy. Initially, due to negative PD-L1 expression, the patient was treated docetaxel, cisplatin and cetuximab combination. Chemotherapy after 10 months, new hepatic progression was confirmed by biopsy. Given the asymptomatic, single-site progression in a cirrhotic liver, microwave ablation was performed. Isolated bone progressions were treated with stereotactic body radiation therapy at 2 and 4 months, and nivolumab replaced cetuximab.

Results: The patient has shown no evidence of disease progression for 22 months, with excellent tolerance.

Conclusion: The synergy between nivolumab and local therapies appears promising for managing oligometastasis in laryngeal cancer.

Related Articles

Sidhart Misra, Zainab Yusufali Motiwala, Ayyaz Mulla, Jagatheswaran Chinnathambi, Danny Darlington Carbin
Muhammad Arif Hameed, Yasmin Abdul Rashid, Insia Ali, Waqas Ahmed Khan, Tasneem Dawood, Misbah Soomro, Mirza Rameez Samar
Aleyamma Mathew, Preethi Sara George, Kondalli Lakshminarayana Sudarshan, Thilagavathi Ramamoorthy, Sreekumar Ananthakrishna, Elizabeth Mathew Iype, Anita Nath